Author’s guidelines for the Journal of Oral Health & Oral Epidemiology
Journal of Oral Health & Oral Epidemiology is the official journal of the Oral and Dental Diseases Research Center of Kerman University of Medical Sciences. The journal publishes original research articles, review articles, and case reports dealing with oral health and epidemiology. Papers in any of the following fields will be considered for publication: oral health, oral and dental treatment research, oral and dental epidemiology, as well as any issues regarding the improvement of oral and dental treatment.
Publishing articles in the Journal of Oral Health & Oral Epidemiology is free of charge.
All JOHOE publications are in English.
Submission of manuscript
The Journal of Oral Health & Oral Epidemiology is using an online submission and peer review. To submit a manuscript, please open the journals website at http://johoe.kmu.ac.ir/author?_action=submit.
1. Title Page
4. Methods and materials
8. Future Recommendations, if any
9. Acknowledgments, if any
A common type of journal manuscript which shows full reports of data from an important issue. It is known as an Original Article, Research Article, Research, or just Article, depending on the journal's opinion. Original research consists of full Introduction, Methods, Results, and Discussion sections. There is no limit for references.
These articles report specific instances of an unusual or novel phenomenon. It is often used to report the occurrence of previously unknown or emerging pathologies, it also could be a literature review of other reported cases.
Case series or clinical series, which tracks patients with a known exposure, which given similar treatment or examines. it could be retrospective or prospective, and depending on that all cases presenting to the reporting authors over a period were included, or only a selection of it, it could be consecutive or nonconsecutive.
Methodologies or Methods
These articles present a novel experimental method, test or procedure, a significant improvement to conventional techniques it could be completely new or may offer a better practice of an existing method.
This type of manuscript provides an authoritative review of the literature, offering a perspective and critical discussion of a certain topic. They may include traditional literature reviews or, meta-analyses. Reviews are often widely read and highly cited.
In this type of article, the authors report one or more health-related interventions such as drugs, cells and biological products, surgical products, devices and behavioral treatments to evaluate the health-related outcome.
Letter to the editor
Letters to the editor or Brief reports will be welcomed for publication if they provide a useful and objective critique. Letters should not exceed 1500 words or ten references, containing data from original research, focused on initial findings that will be of interest to scientists in other fields.
These papers communicate brief reports of data from original research that editors believe will be interesting to many researchers, and that will likely stimulate further research in the field. As they are relatively short the format is useful for scientists with results that are time-sensitive (for example, those in highly competitive or quickly-changing disciplines). This format often has strict length limits, so some experimental details may not be published until the authors write a full Original Research manuscript. These papers are also sometimes called short communications.
We performed template files. You can download it from here:
1. Title page
Parts of manuscript
Manuscripts should be presented as following orders: a) title page, b) structural abstract and keywords, c) introduction, d) method and materials, e) results, f) discussion, g) conclusion, h) acknowledgments, i) references, j) figures, k) tables (each table complete with title and footnotes).
The title page should contain a) the title of the paper, b) the full names of the authors, c) the running title, d) the authors’ affiliation, and d) the full postal and email address of authors. The running title should be a brief version of the title of the paper, no more than 50 characters long including spaces (5-6 words). The running title needs to both make sense as a phrase and give some idea of what the paper is about. We performed a template file for the title page. You can download it from here. Please add your ORCID iD to the title page. You must register with your ORCID iD to distinguish you from other researchers, with a common name.
Abstract and Keywords
All articles must have a structured abstract contains a) background and aim, b) methods, c) results, d) conclusion in 300 words or fewer. At least three keywords should be supplied at the end of the abstract. MeSH can be used for choosing the right keywords.
The main document of the manuscript should not exceed 2000 words except for review and invited articles. The main document should contain: a) introduction, b) method, c) results, d) discussion, and e) conclusion. The case report should contain an abstract, introduction, case report, and discussion. The case report should not exceed 1500 words. All submitted manuscripts should be compatible with word 2007 with font size 12 Book Antiqua and single space between main documents lines.
Describe your selection of the observational or experimental participants (patients or laboratory animals, including controls) clearly, including eligibility and exclusion criteria and a description of the source population. Technical information: Identify the methods, apparatus (give the manufacturer's name, the city, and the country its made by in parentheses), and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods (see below); provide references and brief descriptions for methods that have been published but are not well known; describe new or substantially modified methods, give reasons for using them, and evaluate their limitations. Identify precisely all drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration. Reports of randomized clinical trials should present information on all major study elements, including the protocol, assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding), based on the CONSORT Statement (http://www.consort-statement.org).
Abbreviations, Drug Names, Digits
Use standard abbreviations in the Oral Health and Oral Epidemiology Journal papers without definition in the text. Standard abbreviations, however, should be defined at first mention in the abstract. Each nonstandard (author-defined) abbreviation should be defined in the abstract and text at first mention. If three or more nonstandard abbreviations are used in the text, prepare an abbreviation footnote. The footnote should be associated with the first abbreviated term in the text and should be an alphabetized listing of all author-defined abbreviations and their definitions. Group designations should be defined parenthetically at first mention [for example, "control (CON) and high-fat (HF) groups"] and included in the abbreviation footnote. Abbreviations (other than units such as min, h, m, kg) should be pluralized where appropriate (e.g., The n–3 PUFAs are…) but should not be followed by a period. All nonstandard abbreviations, including group or treatment designations, used in a table or table title, must be defined alphabetically in a footnote to the table title. If the footnote to the table title contains multiple items, the definitions of the abbreviations should be the last item. If a table contains only one abbreviated term in the body of the table, then a separate footnote placed after that abbreviation should be used to define that term. Similarly, all nonstandard abbreviations, including group or treatment designations, used in a figure or figure legend must be defined alphabetically at the end of the figure legend. All drugs’ name (both commercial and generic names); the manufacture, the city, and the country it's made by should be declared.
Statement of human and animal rights
When reporting experiments on human subjects, authors should indicate whether the procedures followed were by the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. If doubt exists whether the research was conducted by the ethical standards, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.
The source of financial support and funding must be acknowledged.
conflict of interest
Conflicts of interest include facts known to a participant in the publication process that if revealed later, would make a reasonable reader feel misled or deceived (or an author, reviewer, or editor feel defensive). Conflicts of interest may influence the judgment of authors, reviewers, and editors; these conflicts often are not immediately apparent to others or to the reviewer. They may be personal, commercial, political, academic, or financial. Financial interests may include employment, research funding (received or pending), stock or share ownership, patents, payment for lectures or travel, consultancies, nonfinancial support, or any fiduciary interest in the company.
The perception or appearance of a conflict of interest, without regard to substance, alone creates conflict, because trust is eroded among all participants. All such interests (or their absence) must be declared in writing by authors upon submission of the manuscript. If any are declared, they should be published with the article. If there is doubt about whether a circumstance represents a conflict, it should be disclosed. Sources of full or partial funding or other support for the research must be declared and should be described in an acknowledgment if the manuscript is published; if anyone besides the authors is involved in analysis, interpretation, or control of the data, this must also be declared. The funding organization’s or sponsor’s role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; and in the preparation, review, or approval of the manuscript should be specified.
Each author should provide a summary conflict of interest statement to be included on the title page of the manuscript. If no author has a conflict of interest, include the following:” the authors have declared that no conflict of interest exists.”
Journal of Oral Health & Oral Epidemiology has instructed authors to use the Vancouver system of referencing. In the main document, references should be cited with parentheses and in order of their appearance in the text. The maximum number of references for scientific articles, case reports and clinical updates are 35, 25, and 20, respectively. Review literature and invited articles have no limit on the number of references. In the reference list, cite the names of all authors when there are six or fewer; when seven or more, list the first six followed by et al. Reference list should contain all references that have been addressed in any part of the manuscript. Names of journals should be abbreviated in the style used in Index Medicus. The authors are responsible for the accuracy of the references.
Tables should not duplicate information that has been described in the text. Table legend should be written above it and all tables should be print in separate pages. At the end of the manuscript Table, the legend should be comprehensive and footnotes must be described for each table separately. All abbreviations must be defined in footnotes.
Illustrations (diagrams and photographs) are classified as figures. The figures should be provided electronically with high resolution (at least 600 d.p.i.) files should be saved as.JEPG or.Tif format. The figures must not be embedded in the word document - they must be uploaded in separate files. Magnifications of microscopic images should be indicated using a scale bar on the illustration or in the figure legend. Figure legends should be written on separate pages at the end of the manuscript. Legends should be brief but comprehensive. Explain all abbreviations and the unit of measurements in the figure legend. If table(s) or figure(s) used from previously published documents, authors should send a permission letter from the copyright holder to the editorial office of the JOHOE.
Submitted papers will be examined for the evidence of plagiarism using PlagScan automated plagiarism detection service. The authors are responsible for plagiarism check. It is very important for the editorial board of the Journal of Oral Health & Oral Epidemiology and the manuscript may be rejected, even if it has been accepted by reviewers.
Review and action process
A submitted manuscript is assigned to the Senior Editor of the appropriate subject section. The Senior Editor assigns it to an Associate Editor who manages and adjudicates its review. The Editors will return manuscripts that are judged to be outside the scope of the journal. Manuscripts can be returned without review for reasons that include:
- Grammar and style that is not of the quality expected in a published article;
- The topic or scope of the work is not within the scope of the journal;
- The presentation of the findings is not directed to the readership of the journal;
- The methods or approaches are judged to be flawed. All editorial board members would receive the submitted manuscript and in a meeting would approve either sending manuscript to referees or rejecting it.
- Manuscripts sent for review are examined by three or more reviewers selected for their expertise in the subject matter of the article. Reviewers will remain anonymous (unless they choose to reveal themselves).
The editorial board members make one of the following decisions on the manuscript:
Accept pending minor revision
Reconsider upon revision
The average time from submission until the decision is expected to be 45 days or less.
Editorial review and acceptance
The editorial board considers all medical research studies based on ICMJE recommendations about the conduction, reporting, and editing of these investigations. The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except for invited papers, submitted manuscripts are peer-reviewed via a double-blinded process by three anonymous reviewers and the journal’s editorial board. Final acceptance or rejection is depending on the editorial board decision on peer-reviewed papers. Manuscripts should be written in a clear, concise, and direct style. The Editorial Board reserves the right to edit accepted papers to be more concise and free of grammatical typos and errors. Following acceptance, an edited form of the paper will be sent to the authors’ correspondence for final review and approval. If extensive alterations are required, the manuscript will be returned to the author for major revision.
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
Authors who publish with this journal agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under an Attribution-NonCommercial 4.0 International that allows
others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Getting Help with Your Submission
Any inquiries should be sent to Mr. Nekouei, Journal of Oral Health & Oral Epidemiology Oral and Dental Diseases Research Center, Qusar Boulevard, Kerman, Iran. Email: email@example.com; firstname.lastname@example.org Tel: +98 34 32126025